Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
D Capodanno, R Mehran, M Valgimigli… - Nature Reviews …, 2018 - nature.com
In patients with manifestations of cardiovascular disease, acetylsalicylic acid (popularly
known as aspirin) has been the mainstay of treatment for decades owing to its capacity to …
known as aspirin) has been the mainstay of treatment for decades owing to its capacity to …
Predictors of stent thrombosis and their implications for clinical practice
Stent thrombosis (ST) is a rare but severe complication of coronary procedures with high
mortality, high relapse rate and a very complex pathophysiology. An individual's …
mortality, high relapse rate and a very complex pathophysiology. An individual's …
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta …
Aims Of patients with atrial fibrillation (AF), approximately 10% undergo percutaneous
coronary intervention (PCI). We studied the safety and efficacy of dual vs. triple …
coronary intervention (PCI). We studied the safety and efficacy of dual vs. triple …
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a …
Aims After percutaneous coronary intervention (PCI) in patients with atrial fibrillation, safety
and efficacy with dabigatran dual therapy were evaluated in pre-specified subgroups of …
and efficacy with dabigatran dual therapy were evaluated in pre-specified subgroups of …
Dual anticoagulant/antiplatelet activity of polyphenolic grape seeds extract
M Bijak, A Sut, A Kosiorek, J Saluk-Bijak, J Golanski - Nutrients, 2019 - mdpi.com
Because of the side-effects of commonly used anti-platelet and anticoagulant drugs,
investigations into plant substances with similar activities are very common. Based on our …
investigations into plant substances with similar activities are very common. Based on our …
Effect of direct oral anticoagulants, warfarin, and antiplatelet agents on risk of device pocket hematoma: combined analysis of BRUISE CONTROL 1 and 2
Background: Oral anticoagulant use is common among patients undergoing pacemaker or
defibrillator surgery. BRUISE CONTROL (Bridge or Continue Coumadin for Device Surgery …
defibrillator surgery. BRUISE CONTROL (Bridge or Continue Coumadin for Device Surgery …
Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
ND Brunetti, N Tarantino, L De Gennaro… - Open …, 2018 - openheart.bmj.com
The coexistence of coronary artery disease and atrial fibrillation (AF) in the same individuals
raises great concern about the co-treatment with different antithrombotic agents in the case …
raises great concern about the co-treatment with different antithrombotic agents in the case …
[HTML][HTML] Screening for the antiplatelet aggregation quality markers of Salvia yunnanensis based on an integrated approach
Y Li, Y Zhang, B Cao, F Zhang, M Niu, X Bai… - … of Pharmaceutical and …, 2020 - Elsevier
This study aimed to identify the antiplatelet aggregation quality markers of Salvia
yunnanensis (SY) based on an integrated approach. The effects of SY methanol extracts on …
yunnanensis (SY) based on an integrated approach. The effects of SY methanol extracts on …
Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous …
GYH Lip, L Mauri, G Montalescot, M Ozkor… - American Heart …, 2019 - Elsevier
Background In the RE-DUAL PCI trial of patients with atrial fibrillation (AF) who underwent
percutaneous coronary intervention (PCI), dabigatran dual therapy (110 or 150 mg bid, plus …
percutaneous coronary intervention (PCI), dabigatran dual therapy (110 or 150 mg bid, plus …
A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary …
AE Sullivan, MG Nanna, SV Rao… - Catheterization and …, 2020 - Wiley Online Library
Background Prior randomized controlled trials (RCT) evaluating the optimal antithrombotic
therapies for patients with atrial fibrillation (AF) undergoing percutaneous coronary …
therapies for patients with atrial fibrillation (AF) undergoing percutaneous coronary …